D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.67% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
CALL
Murphy Oil
MUR
$4.74B
| $1.03M | ﹤0.01% |
+33,900
| New | +$1.09M |
|
3052
CALL
RingCentral
RNG
$5.18B
| $1.02M | ﹤0.01% |
29,200
-5,500
| -16% | -$198K |
|
3053
CALL
MakeMyTrip
MMYT
$5.65B
| $1.02M | ﹤0.01% |
9,100
-21,900
| -71% | -$2.35M |
|
|
PDCO
3054
DELISTED
Patterson Companies, Inc.
PDCO
| $1.02M | ﹤0.01% |
32,953
-148,620
| -82% | -$3.45M |
|
3055
CALL
Lyft
LYFT
$6.19B
| $1.02M | ﹤0.01% |
78,800
+26,300
| +50% | +$390K |
|
|
APLS
3056
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $1.01M | ﹤0.01% |
31,700
| – | – |
|
|
HTO
3057
H2O America
HTO
$2.59B
| $1.01M | ﹤0.01% |
20,548
-2,205
| -10% | -$121K |
|
3058
HP
HPQ
$25.8B
| $1.01M | ﹤0.01% |
30,992
-16,283
| -34% | -$585K |
|
3059
Simplify Health Care ETF
PINK
$382M
| $1.01M | ﹤0.01% |
34,074
-13,710
| -29% | -$432K |
|
|
CAPN
3060
Cayson Acquisition Corp
CAPN
| $1.01M | ﹤0.01% |
+100,000
| New | +$999K |
|
3061
iShares Russell 2000 Growth ETF
IWO
$14.8B
| $1.01M | ﹤0.01% |
3,496
-14,646
| -81% | -$4.33M |
|
|
NVMI
3062
CALL
Nova
NVMI
$12.1B
| $1M | ﹤0.01% |
5,100
-9,400
| -65% | -$1.81M |
|
3063
PUT
Herbalife
HLF
$1.19B
| $1M | ﹤0.01% |
150,000
| – | – |
|
3064
Terex
TEX
$7.47B
| $998K | ﹤0.01% |
21,593
-43,259
| -67% | -$2.26M |
|
|
AKRO
3065
DELISTED
Akero Therapeutics
AKRO
| $996K | ﹤0.01% |
35,809
-80,573
| -69% | -$2.44M |
|
|
CIM
3066
Chimera Investment
CIM
$992M
| $993K | ﹤0.01% |
70,902
-144,787
| -67% | -$2.17M |
|
|
APLS
3067
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $989K | ﹤0.01% |
+31,000
| New | +$932K |
|
3068
Lennox International
LII
$15.1B
| $987K | ﹤0.01% |
1,620
-473
| -23% | -$296K |
|
|
ENFN
3069
DELISTED
Enfusion, Inc.
ENFN
| $986K | ﹤0.01% |
95,697
+65,475
| +217% | +$633K |
|
3070
ATS Corp
ATS
$1.99B
| $985K | ﹤0.01% |
32,300
-38,289
| -54% | -$1.16M |
|
3071
Aaon
AAON
$7.39B
| $983K | ﹤0.01% |
8,352
-15,387
| -65% | -$1.89M |
|
3072
PUT
Kohl's
KSS
$2.09B
| $983K | ﹤0.01% |
70,000
| – | – |
|
3073
PUT
General Mills
GIS
$19.3B
| $982K | ﹤0.01% |
+15,400
| New | +$1.03M |
|
3074
CALL
Summit Therapeutics
SMMT
$10.8B
| $981K | ﹤0.01% |
+55,000
| New | +$1.07M |
|
3075
PUT
Sociedad Química y Minera de Chile
SQM
$20.7B
| $978K | ﹤0.01% |
26,900
-69,900
| -72% | -$2.74M |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.